000 01320 a2200361 4500
005 20250515145933.0
264 0 _c20090327
008 200903s 0 0 eng d
022 _a1420-9071
024 7 _a10.1007/s00018-008-8536-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZauli, G
245 0 0 _aRole of full-length osteoprotegerin in tumor cell biology.
_h[electronic resource]
260 _bCellular and molecular life sciences : CMLS
_cMar 2009
300 _a841-51 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aCell Survival
650 0 4 _aEndothelial Cells
_xcytology
650 0 4 _aHumans
650 0 4 _aImmunoglobulin G
_xgenetics
650 0 4 _aNeoplasms
_xmetabolism
650 0 4 _aNeovascularization, Physiologic
650 0 4 _aOsteoclasts
_xcytology
650 0 4 _aOsteoprotegerin
_xgenetics
650 0 4 _aRANK Ligand
_xgenetics
650 0 4 _aRecombinant Fusion Proteins
_xgenetics
650 0 4 _aTNF-Related Apoptosis-Inducing Ligand
_xmetabolism
700 1 _aMelloni, E
700 1 _aCapitani, S
700 1 _aSecchiero, P
773 0 _tCellular and molecular life sciences : CMLS
_gvol. 66
_gno. 5
_gp. 841-51
856 4 0 _uhttps://doi.org/10.1007/s00018-008-8536-x
_zAvailable from publisher's website
999 _c18469028
_d18469028